Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules - PubMed (original) (raw)
. 2011 Jan;21(1):196-204.
doi: 10.1038/cr.2010.142. Epub 2010 Oct 19.
Qiang Zhang, Xiaolei Yin, Weifeng Yang, Yuanyuan Du, Pingping Hou, Jian Ge, Chun Liu, Weiqi Zhang, Xu Zhang, Yetao Wu, Honggang Li, Kang Liu, Chen Wu, Zhihua Song, Yang Zhao, Yan Shi, Hongkui Deng
Affiliations
- PMID: 20956998
- PMCID: PMC3193405
- DOI: 10.1038/cr.2010.142
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules
Yanqin Li et al. Cell Res. 2011 Jan.
Abstract
The introduction of four transcription factors Oct4, Klf4, Sox2 and c-Myc by viral transduction can induce reprogramming of somatic cells into induced pluripotent stem cells (iPSCs), but the use of iPSCs is hindered by the use of viral delivery systems. Chemical-induced reprogramming offers a novel approach to generating iPSCs without any viral vector-based genetic modification. Previous reports showed that several small molecules could replace some of the reprogramming factors although at least two transcription factors, Oct4 and Klf4, are still required to generate iPSCs from mouse embryonic fibroblasts. Here, we identify a specific chemical combination, which is sufficient to permit reprogramming from mouse embryonic and adult fibroblasts in the presence of a single transcription factor, Oct4, within 20 days, replacing Sox2, Klf4 and c-Myc. The iPSCs generated using this treatment resembled mouse embryonic stem cells in terms of global gene expression profile, epigenetic status and pluripotency both in vitro and in vivo. We also found that 8 days of Oct4 induction was sufficient to enable Oct4-induced reprogramming in the presence of the small molecules, which suggests that reprogramming was initiated within the first 8 days and was independent of continuous exogenous Oct4 expression. These discoveries will aid in the future generation of iPSCs without genetic modification, as well as elucidating the molecular mechanisms that underlie the reprogramming process.
Figures
Figure 1
Generation of iPSCs from fibroblasts by Oct4 and small molecules. (A) GFP+/iPS-like colony numbers induced from OG-MEFs transduced with Oct4/Sox2/Klf4. VPA and CHIR99021 greatly improved the efficiency of GFP+/iPS-like colony generation (approximately 30-fold). Approximately 30 iPS colonies were generated from 1 × 104 MEFs at day 15 after infection. Similar results were obtained in three independent experiments. “V” stands for VPA. “VC” stands for the combination of VPA and CHIR99021. (B) GFP+/iPS-like colony numbers induced from OG-MEFs transduced with Oct4/Klf4, in combination with VPA, CHIR99021 and 616452 (VC6). Approximately 5-20 GFP+/iPS-like colonies were generated from 5 × 104 MEFs at day 15 after infection. Similar results were obtained in three independent experiments. (C) GFP+/iPS-like colony numbers induced from OG-MEFs transduced with Oct4/Sox2/Klf4. Tranylcypromine significantly promoted iPSC generation (approximately 20-fold), with an efficiency similar to that of VPA. When VPA and tranylcypromine were added together (VT), iPSC generation efficiency was further increased. The number of iPS colonies generated from 1 × 104 MEFs was counted on day 15 after infection. Similar results were obtained in three independent experiments. “V” stands for VPA. “T” stands for tranylcypromine. (D) A typical GFP+/iPS-like colony generated from MEFs (left) and adult fibroblasts (right) after 30 days of Oct4 and VC6 treatment. (E) Timeline of _Oct4_-iPSC generation using one single factor Oct4 and small molecule treatment (VC6T: VPA, CHIR99021, 616452 and tranylcypromine). Culture medium containing small molecules was changed every four days. (F) GFP+ colonies appeared 18 days after OG-MEFs were transduced with Oct4 and treated with VC6T. Bars, 500 μm. (G) Genome PCR showed that these _Oct4_-iPSCs had only the exogenous Oct4 insertion and were free of other exogenous factors (1a,1b,1c: _Oct4_-iPSC lines from MEFs of ICR×OG genetic background; 2a,2b: _Oct4_-iPSC lines from MEFs of 129×OG genetic background; 3a,3b: _Oct4_-iPSC lines from MEFs of C57×OG genetic background; 4f-iPS: iPSCs induced by the original four transcriptional factors, Oct4, Sox2, Klf4 and c-Myc as positive control).
Figure 2
Oct4 induced iPSCs to express pluripotency markers and resemble ESCs. _Oct4_-induced iPSCs maintained ESC-like morphology, AP activity and GFP expression in mESC growth media (bars, 500 μm), while expressing pluripotency markers Oct4, Nanog, Utf1, Rex1 and SSEA1, detected by immunofluorescence (bars, 100 μm). (A) RT-PCR analysis showed the pluripotent marker gene expression of these _Oct4_-iPSCs (1a,1b,1c: three separate _Oct4_-iPSC lines from MEFs of ICR×OG genetic background; 3a,3b: two separate _Oct4_-iPSC lines from MEFs of 129×OG genetic background). (B) DNA methylation analysis of several CpG sites in the Nanog and Oct4 promoters, indicating that the demethylation of Nanog and Oct4 promoters in _Oct4_-iPSCs was similar to that of mESCs. Nanog and Oct4 promoters of MEFs were hypermethylated. (C) Microarray analyses showed a similar global gene expression profile among _Oct4_-iPSCs, 4F-iPSCs and mESCs (R1), which were quite different from that of OG-MEFs.
Figure 3
Differentiation potential of _Oct4_-iPSCs. (A) Teratoma formation of _Oct4_-iPSCs. The tissues of all three germ layers, such as pigmented retinal epithelium, cartilage, neural tube-like epithelium and gut-like epithelium, were detected in these _Oct4_-iPSC-derived teratoma sections. Bars, 200 μm. (B) When the _Oct4_-iPSC aggregated embryos were transplanted into mice, GFP+ cells were detected in the gonad tissues of 17 days post copulation embryos, which suggests that the iPS cell contribution to the germ line. (C) Adult mice with a high degree of chimerism were developed from _Oct4_-iPSC lines generated from MEFs (left) and adult fibroblasts (rigtht), after blastocyst transplantation. (D) Genome PCR showed that these _Oct4_-iPSCs contributed to brain, lung, tail, liver, heart, stomach, testis, kidney, spleen and skin in a chimeric mouse. Tail fibroblasts from ICR and 129 mice were used as negative control. Tail fibroblasts from OG2 mice and MEFOG, which have p_Oct4_-GFP alleles in their genomes, were used as positive control.
Figure 4
The efficiency of iPSC generation with DOX-inducible Oct4 expression and VC6T treatment. (A) iPSC colony numbers generated by different induction time of Oct4 using the tet-on system. Doxycycline (dox) was added at different time periods during the reprogramming process as shown on the x axis. The various shaded bars indicate the days on which colonies appeared in the culture. Similar results were obtained in three independent experiments. (B) iPSC colony numbers generated by different treatment times. The numbers on x axis stand for the days with VC6T treatment from day 0 after transduction. Dox was added during the entire process to induce Oct4 expression. Colony numbers were calculated at days 12, 15, 18, 21 and 24, shown by various shaded bars. Results were obtained in three independent experiments.
Similar articles
- NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T, Markov GJ, Brady JJ, Palla A, Zeng H, Sebastiano V, Blau HM. Mai T, et al. Nat Cell Biol. 2018 Aug;20(8):900-908. doi: 10.1038/s41556-018-0136-x. Epub 2018 Jul 16. Nat Cell Biol. 2018. PMID: 30013107 Free PMC article. - Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK, Kumar N, Kalsan M, Saini A, Chandra R. Singh VK, et al. J Stem Cells. 2015;10(1):43-62. J Stem Cells. 2015. PMID: 26665937 Review. - Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U, Sgodda M, Warlich E, Ballmaier M, Schöler HR, Schambach A, Cantz T. Tiemann U, et al. Cytometry A. 2011 Jun;79(6):426-35. doi: 10.1002/cyto.a.21072. Epub 2011 May 4. Cytometry A. 2011. PMID: 21548079 - Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K, Kato T, Chen C, Oinam L, Shiomitsu E, Ayakawa D, Ohtaka M, Fukuda A, Nakanishi M, Hisatake K. Nishimura K, et al. Stem Cell Reports. 2014 Nov 11;3(5):915-29. doi: 10.1016/j.stemcr.2014.08.014. Epub 2014 Oct 2. Stem Cell Reports. 2014. PMID: 25418733 Free PMC article. - SCNT versus iPSCs: proteins and small molecules in reprogramming.
Han F, Li X, Song D, Jiang S, Xu Q, Zhang Y. Han F, et al. Int J Dev Biol. 2015;59(4-6):179-86. doi: 10.1387/ijdb.150042fh. Int J Dev Biol. 2015. PMID: 26505250 Review.
Cited by
- Manipulating cell fate through reprogramming: approaches and applications.
Yagi M, Horng JE, Hochedlinger K. Yagi M, et al. Development. 2024 Oct 1;151(19):dev203090. doi: 10.1242/dev.203090. Epub 2024 Sep 30. Development. 2024. PMID: 39348466 Review. - An Efficient Direct Conversion Strategy to Generate Functional Astrocytes from Human Adult Fibroblasts.
Bhaskar U, Shrimpton E, Ayo J, Prasla A, Kos MZ, Carless MA. Bhaskar U, et al. bioRxiv [Preprint]. 2024 Sep 3:2024.09.02.610876. doi: 10.1101/2024.09.02.610876. bioRxiv. 2024. PMID: 39282386 Free PMC article. Preprint. - Experimental study on small molecule combinations inducing reprogramming of rat fibroblasts into functional neurons.
Gao Q, Dai Z, Yang X, Liu C, Liu G. Gao Q, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Aug 25;53(4):498-508. doi: 10.3724/zdxbyxb-2024-0007. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39183062 Free PMC article. Chinese, English. - Advances in induced pluripotent stem cell-derived cardiac myocytes: technological breakthroughs, key discoveries and new applications.
Clancy CE, Santana LF. Clancy CE, et al. J Physiol. 2024 Aug;602(16):3871-3892. doi: 10.1113/JP282562. Epub 2024 Jul 20. J Physiol. 2024. PMID: 39032073 Review. - Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
Pazzin DB, Previato TTR, Budelon Gonçalves JI, Zanirati G, Xavier FAC, da Costa JC, Marinowic DR. Pazzin DB, et al. Cells. 2024 Apr 25;13(9):745. doi: 10.3390/cells13090745. Cells. 2024. PMID: 38727281 Free PMC article. Review.
References
- Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. - PubMed
- Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. - PubMed
- Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature. 2007;448:313–317. - PubMed
- Wernig M, Meissner A, Foreman R, et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007;448:318–324. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials